Year: 2024

LA JOLLA, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a pending patent application for MN-001 (Tipelukast) to cover “Method to Decrease Triglyceride Synthesis in a Liver of a Subject.” The allowed claims cover a groundbreaking method for decreasing triglyceride synthesis in the liver by administering MN-001 (Tipelukast) or its metabolite or pharmaceutically acceptable salt. This method is particularly beneficial for subjects diagnosed with insulin resistance, pre-diabetes, or diabetes. Once issued, this patent is expected to expire no earlier than May...

NORWELL, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the second fiscal quarter ended September 30, 2024, and a restatement of the financial results for the first fiscal quarter ended June 30, 2024, to account for the timing of revenue and associated cost of sales recognition for two devices sold in late June 2024. Recent HighlightsRevenue of $18.2 million for the quarter ended September 30, 2024, representing growth of 39% over...

Company successfully listed on Nasdaq under the symbol “AIFF” Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering with brain health illnesses by bringing objective measurement of brain activity to the front lines of healthcare. The Company’s go-to-market strategies...

Major Advances in Financial Controls and Cost Management Pave the Way for Sustainable Operations and Market Leadership TEMPE, Ariz., Nov. 14, 2024 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety solutions, today announced key financial and operational achievements for the third quarter ended September 30, 2024. Key Highlights:Significant Cost Reductions: Operating expenses slashed by 22% year-over-year, falling to $3.9 million from $4.9 million in Q3 2023, reflecting efficiency gains. Monetizing Inventory: Ongoing cost-saving measures and paused manufacturing have allowed the Company to focus on monetizing a $25 million finished goods inventory and reinforce a leaner operational model. Increase in Reported Subscription Services: Subscription services...

BALTIMORE, Nov. 14, 2024 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared today a year-end distribution of $1.96 per share. The total distributions by the Fund for 2024 will be $2.50 per share, including the distributions totaling $0.54 per share made in 2024 prior to today’s announcement. The annual distribution rate represented by these distributions is 10.9%. The Fund’s estimated sources for the distribution to be paid on December 23, 2024 and for all distributions declared in 2024 to date are as follows:  Distribution per Share Net Investment Income Net Realized Short-Term Gains Net Realized Long-Term Gains Return of CapitalDecember 23, 2024 $1.96 $0.04 (2%) $0.30 (15%) $1.62 (83%) $0.00 (0%)YTD 2024 $2.50 $0.17 (7%) $0.30 (12%) $2.03 (81%) $0.00 (0%)Fund Performance and Distribution Rate...